0.5903
전일 마감가:
$0.5958
열려 있는:
$0.5793
하루 거래량:
1.82M
Relative Volume:
0.12
시가총액:
$25.33M
수익:
-
순이익/손실:
$-23.36M
주가수익비율:
-0.8012
EPS:
-0.7368
순현금흐름:
-
1주 성능:
-19.14%
1개월 성능:
+156.65%
6개월 성능:
-22.14%
1년 성능:
-64.65%
Calidi Biotherapeutics Inc Stock (CLDI) Company Profile
명칭
Calidi Biotherapeutics Inc
전화
(858) 794-9600
주소
4475 Executive Drive, Suite 200, San Diego
CLDI을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
CLDI
Calidi Biotherapeutics Inc
|
0.5903 | 20.57M | 0 | -23.36M | 0 | -0.7368 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2023-11-22 | 개시 | H.C. Wainwright | Buy |
2023-10-09 | 개시 | Robert W. Baird | Outperform |
Calidi Biotherapeutics Inc 주식(CLDI)의 최신 뉴스
What is Calidi Biotherapeutics Inc. company’s growth strategyAchieve breakthrough gains with smart trades - jammulinksnews.com
Is it the right time to buy Calidi Biotherapeutics Inc. stockExtraordinary performance - jammulinksnews.com
Does Calidi Biotherapeutics Inc. stock perform well during market downturnsGet timely advice on market trends - jammulinksnews.com
Is Calidi Biotherapeutics Inc. a growth stock or a value stockAchieve consistent profits with smart trading - jammulinksnews.com
What are analysts’ price targets for Calidi Biotherapeutics Inc. in the next 12 monthsBuild a winning portfolio with smart picks - jammulinksnews.com
What makes Calidi Biotherapeutics Inc. stock price move sharplyDiscover high-impact stocks for growth - jammulinksnews.com
Is Calidi Biotherapeutics Inc. stock overvalued or undervaluedExceptional trading results - jammulinksnews.com
What are the technical indicators suggesting about Calidi Biotherapeutics Inc.Pre Market Entry Points To Watch Now - jammulinksnews.com
Atossa Therapeutics and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Weatherford Democrat
Chart based analysis of Calidi Biotherapeutics Inc. trendsChart Driven High Reward Trading Setup Presented - metal.it
Live Scanner Shows Breakout on Calidi Biotherapeutics Inc.Real Time Alerts Based on AI Prediction Triggered - metal.it
Calidi Biotherapeutics Stock Plunges 10.6% Despite FDA Fast Track Designation - AInvest
Is it too late to sell Calidi Biotherapeutics Inc.AI Screener Based Stock Summary Report - Newser
What risks could impact Calidi Biotherapeutics Inc. stock performanceFree Stock Screener With Smart Filters - Newser
Candlestick signals on Calidi Biotherapeutics Inc. stock todayLong-Term Stock Growth Forecast Insights - Newser
Calidi Biotherapeutics Receives FDA Fast Track Designation - GlobeNewswire
Short Covering May Lift Calidi Biotherapeutics Inc. in Near TermShort Term High Yield Stock Tips for Active Traders - metal.it
Calidi Biotherapeutics Stock Soars 68% on FDA Fast Track Designation - AInvest
Calidi Biotherapeutics Receives FDA Fast Track Designation for CLD-201 (SuperNova), a First-In-Class Stem-Cell Loaded Viral Therapy for the Treatment of Patients with Soft Tissue Sarcoma - The Manila Times
FDA grants fast track designation to Calidi’s CLD-201 for sarcoma - Investing.com Nigeria
FDA Fast-Tracks Revolutionary Stem Cell-Viral Therapy for Aggressive Cancer Treatment - Stock Titan
Is Calidi Biotherapeutics Inc. a Top Dividend Stock to Watch in 2025Early Entry Ideas with Momentum Potential - Newser
Calidi Biotherapeutics Inc. Stock Support and Resistance Levels You Should KnowValue Investing Checklist with Entry Signals - Newser
Why Calidi Biotherapeutics Inc. stock attracts strong analyst attentionMarket Ready Picks with Technical Support - Newser
Published on: 2025-07-29 02:14:07 - Newser
Calidi Biotherapeutics Announces 1-for-12 Reverse Stock Split to Optimize Market Dynamics - citybuzz -
How to forecast Calidi Biotherapeutics Inc. trends using time seriesPrice Action Summary and Entry Strategy Guide - Newser
How to interpret RSI for Calidi Biotherapeutics Inc. stockShort Term Opportunity Finder with Tools - Newser
Why Did Calidi Biotherapeutics Stock Plunge 10.55%? - AInvest
How does Calidi Biotherapeutics Inc. compare to its industry peersInvest confidently with professional guidance - jammulinksnews.com
How volatile is Calidi Biotherapeutics Inc. stock compared to the marketHigh-yield market plays - jammulinksnews.com
Buy Signal for Calidi Biotherapeutics Inc. Stock Key Technical Indicators to WatchSmart Trading With Safety Margin - Newser
Calidi announces reverse stock split, expected to begin trading on a 1-for-12 split adjusted basis - MSN
Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025 - GlobeNewswire
Calidi announces 1-for-12 reverse stock split - TipRanks
Calidi Biotherapeutics' 1-for-12 Reverse Stock Split: Strategic Rebranding or a Desperate Lifeline? - AInvest
Calidi Biotherapeutics Announces 1-for-12 Reverse Stock Split to Enhance Market Appeal - Quiver Quantitative
Calidi Biotech Plans Major 1:12 Reverse Split: What Shareholders Must Know Before August 5 - Stock Titan
What analysts say about Calidi Biotherapeutics Inc. stockExplosive returns - PrintWeekIndia
Is Calidi Biotherapeutics Inc. a good long term investmentMassive portfolio appreciation - PrintWeekIndia
Is Calidi Biotherapeutics Inc. stock overhyped or has real potentialTriple-digit returns - jammulinksnews.com
What drives Calidi Biotherapeutics Inc. stock priceRapid wealth creation - PrintWeekIndia
Calidi Biotherapeutics Inc (CLDI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):